References
- International Diabetes Federation. 2016. IDF Diabetic Atlas 7th Edition. http://www.idf.org/idf-diabetes-atlas-seventh-edition
- Mohapatra D, Damodar KS. Glycaemia status, lipid profile and renal parameters in progressive diabetic neuropathy. J Clin Diagn Res. 2016;10:14–17.
- Mishra M, Kumar H, Bajpai S, et al. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes. Diabetes Res Clin Pract. 2011;94:255–261.
- Nukada H. Ischemia and diabetic neuropathy. Handb Clin Neurol. 2014;126:469–487.
- Kowluru RA, Kowluru A, Mishra M, et al. Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res. 2015;48:40–61.
- Klein R, Klein BE, Moss SE, et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. Jama. 1988;260:2864–2871.
- Klein R, Klein BE, Moss SE, et al. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med. 1994;154:2169–2178.
- Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol. 2003;136:122–135.
- Biswas S, Chida AS, Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol. 2006;71:551–564.
- Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48:749–762.
- Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med. 2013;65:244–253.
- Hansen RE, Roth D, Winther JR. Quantifying the global cellular thiol-disulfide status. Proc Natl Acad Sci U S A. 2009;106:422–427.
- Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47:326–332.
- Hazini A, Cemek M, Işıldak İ, et al. Investigation of ischemia modified albumin, oxidant and antioxidant markers in acute myocardial infarction. Postepy Kardiol Interwencyjnej. 2015;11:298–303.
- Hacker M, Hoyer HX, la Fougère C, et al. Effects of peripheral vascular intervention on ischemia-modified albumin. Coron Artery Dis. 2007;18:375–379.
- Cichota LC, Moresco RN, Duarte MM, et al. Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J Clin Lab Anal. 2008;22:1–5.
- Borderie D, Allanore Y, Meune C, et al. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem. 2004;50:2190–2193.
- Chawla R, Loomba R, Guru D, et al. Ischemia modified albumin (IMA) – a marker of glycaemic control and vascular complications in type 2 diabetes mellitus. J Clin Diagn Res. 2016;10:13–16.
- Early treatment diabetic retinopathy Study design and baseline characteristics. ETDRS report number 7. Ophthalmology. 1991;98:741–756.
- Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000;19:311–315.
- West IC. Radicals and oxidative stress in diabetes. Diabet Med. 2000;17:171–180.
- Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys. 2005;43:289–330.
- Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007;2007:43603.
- Arıkan Yorgun M, Toklu Y, Altınkaynak H, et al. A novel tool for the assessment oxidative stress in age-related macular degeneration: thiol/disulfide homeostasis revisited. revisited. Curr Eye Res. 2016;41:1584–1589.
- Turkoglu EB, Dikci S, Çelik E, et al. Thiol/disulfide homeostasis in patients with central serous Chorioretinopathy. Curr Eye Res. 2016;41:1489–1491.
- Tetikoğlu M, Aktas S, Sağdik HM, et al. Thiol disulfide homeostasis in pseudoexfoliation syndrome. Curr Eye Res. 2017;42:876–879.
- Ates I, Kaplan M, Yuksel M, et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine. 2016;51:47–51.
- Ates I, Kaplan M, Inan B, et al. How does thiol/disulfide homeostasis change in prediabetic patients?. Diabetes Res Clin Pract. 2015;110:166–171.
- Ozler S, Oztas E, Caglar AT, et al. Thiol/disulfide homeostasis in predicting adverse perinatal outcomes at 24-28 weeks of pregnancy in gestational diabetes. J Matern Fetal Neonatal Med. 2016;29:3699–3704.
- Kirboga K, Ozec AV, Kosker M, et al. The association between diabetic retinopathy and levels of ischemia-modified albumin, total thiol, total antioxidant capacity, and total oxidative stress in serum and aqueous humor. J Ophthalmol. 2014;2014:820853.
- Glowacki R, Bald E. Fully automated method for simultaneous determination of total cytein, cysteinglycine, glutathione and homocysteine in plasma by HPLC with UV absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:3400–3404.
- Chen W, Zhao Y, Seefeldt T, et al. Determination of thiols and disulfides via HPLC quantification of 5-thio-2-nitrobenzoic acid. J Pharm Biomed Anal. 2008;48:1375–1380.
- Anraku M, Yamasaki K, Maruyama T, et al. Effect of oxidative stress on the structure and function of human serum albumin. Pharm Res. 2001;18:632–639.
- Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia-modified albumin level in type 2 diabetes mellitus - preliminary report. Dis Markers. 2008;24:311–317.
- Ukinc K, Eminagaoglu S, Ersoz HO, et al. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine. 2009;36:425–432.
- Reddy VS, Agrawal P, Sethi S, et al. Associations of FPG, A1C and disease duration with protein markers of oxidative damage and antioxidative defense in type 2 diabetes and diabetic retinopathy. Eye (Lond). 2015;29:1585–1593.
- Kaefer M, Piva SJ, De Carvalho JA, et al. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem. 2010;43:450–454.
- Turk A, Nuhoglu I, Mentese A, et al. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde. Retina. 2011;31:602–608.
- Seshadri Reddy V, Sethi S, Gupta N, et al. Significance of ischemia-modified albumin as a simple measure of oxidative stress and its discriminatory ability in diabetic retinopathy: literature review and meta-analysis. Retina. 2016;36:1049–1057.
- Beetham R, Monk C, Keating L, et al. Effects of storage at −20 degrees C on ischaemia-modified albumin results. Ann Clin Biochem. 2006;43:500–502.